STRUCTURE AND FUNCTION OF VLA INTEGRINS - DIFFERENTIAL EXPRESSION IN B-CELL LEUKEMIA-LYMPHOMA

被引:25
作者
BALDINI, LGM
CRO, LM
机构
[1] Servizio di Ematologia, Centro G. Marcora, Ospedale Maggiore IRCCS, Milan
关键词
INTEGRINS; VERY LATE ANTIGENS (VLA); EXTRACELLULAR MATRIX (ECM); B-CELL LEUKEMIA LYMPHOMA;
D O I
10.3109/10428199409059590
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The integrin family of adhesion receptors includes at least 11 different alpha subunits and 6 different beta subunits which are associated to form 14 different alphabeta heterodimers, divided into three subfamilies. In particular, beta1 subfamily integrins (VLA 1-6 proteins) have been found to mediate cell adhesion to extracellular matrix (ECM) component such as fibronectin, collagen, laminin; however, VLA-4 has been found to exhibit both cell-cell and cell-matrix adhesion functions. The reactivity of VLAs is virtually ubiquitous and independent of line or tissue specificity. However, the expression of individual VLAs within single tissues can be modulated according to the type or functional status of the cell. One of the main reasons for interest in these molecules is that they may play a determining role in neoplastic transformation and diffusion; in particular, in lymphoproliferative syndromes, a lack of cell adhesiveness or an abnormal adhesion pattern in neoplastic lymphocytes may free these cells from regulation, thus contributing towards the development of leukemia and/or lymphoma. Studies of VLA expression in B-cell leukemia/lymphomas show a modulation of VLA3 and VLA4 reactivity. The most interesting element is the identification of a VLA3/VLA4 pattern associated with B-cell chronic lymphocytic leukemia (B-CLL) characterised by a reduced expression of VLA4 and the constant expression of VLA3. Although the value of VLA3 as an additional marker for the diagnosis of classical B-CLL is indisputable, the biological/functional significance of this reactivity remains to be confirmed.
引用
收藏
页码:197 / 203
页数:7
相关论文
共 29 条
  • [1] Hemler M.E., Sanchez-Madrid F., Flotte T.J., Krensky A.M., Burakoff S.J., Bhan A.K., Springer T.A., Strominger J.L., Glycoprotein of 210 000 and 130 000 m.w. on activated T cell: cell distribution and antigenic relation to component on resting cells and T-cell lines, J. Immunol., 132, pp. 3011-3018, (1984)
  • [2] Patarroyo M., Prieto J., Rincon J., Timonen T., Lundberg C., Lindbom L., Asjo B., Gahmberg C.G., Leucocyte cell adhesion: A molecular process fundamental in leukocyte physiology, Immunol. Rev., 114, pp. 67-108, (1990)
  • [3] Arnout M., Structure and function of the leukocyte adhesion molecules CD11/CD18, Blood, 75, pp. 1037-1050, (1990)
  • [4] Baldini L., Cro L., Calori R., Nobili L., Silvestris I., Maiolo A.T., Blood, 79, pp. 2688-2693, (1992)
  • [5] Kajiiji S., Tamura R.N., Quaranta V., A novel integrin (alphaE beta4) from human epithelial cells suggest a fourth family of integrin adhesion receptor, EMBO J., 8, pp. 673-680, (1989)
  • [6] Hemler M.E., Crouse C., Sonnenberg A., Association of the VLA alpha 6 subunit with a novel protein. A possible alternative to the common VLA β 1 subunits on certain cell lines, J. Biol. Chem., 264, pp. 6529-6535, (1989)
  • [7] Cheresh D.A., Smith J.W., Cooper H.M., Quaranta V., A novel vitronectin receptor integrin (alpha v beta x) is responsible for distinct adhesive properties of carcinoma cells, Cell, 57, pp. 59-69, (1989)
  • [8] Holzmann B., Weismann I.L., Peyer's Patch specific lymphocyte homing receptors consist of a VLA-4-like alpha chain associated with either of two integrin beta chains, one of which is novel, EMBO J., 8, pp. 1735-1741, (1989)
  • [9] Hynes R.O., Integrins: versatility, modulation, and signaling in cell adhesion, Cell, 69, pp. 11-25, (1992)
  • [10] Pierschbacher E.M., New perspectives in cell adhesion: RGD and integrins, Science, 238, pp. 491-497, (1987)